Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa
Formáid:	Artigo
Teanga:	Béarla
Foilsithe / Cruthaithe:	2001
Rochtain ar líne:	https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
de réir: Ryutaro Oba, et al.
Foilsithe / Cruthaithe: (2005)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
de réir: Zou, Kun, et al.
Foilsithe / Cruthaithe: (2007)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
de réir: Assarsson, Anna, et al.
Foilsithe / Cruthaithe: (2014)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
de réir: Anna Assarsson, et al.
Foilsithe / Cruthaithe: (2014)

New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
de réir: Yuji Yoshiike, et al.
Foilsithe / Cruthaithe: (2001)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ<sub>1–42</sub>) to Aβ<sub>1–40</sub>, and Its Inhibition Enhances Brain Aβ Deposition
de réir: Kun Zou, et al.
Foilsithe / Cruthaithe: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
de réir: Wisniewski, Thomas, et al.
Foilsithe / Cruthaithe: (2008)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
de réir: Abelein, Axel, et al.
Foilsithe / Cruthaithe: (2015)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
de réir: Axel Abelein, et al.
Foilsithe / Cruthaithe: (2015)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
de réir: Joshi, P, et al.
Foilsithe / Cruthaithe: (2014)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
de réir: P. Joshi, et al.
Foilsithe / Cruthaithe: (2013)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
de réir: Zou, Kun, et al.
Foilsithe / Cruthaithe: (2009)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
de réir: Kun Zou, et al.
Foilsithe / Cruthaithe: (2009)

TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity
de réir: Fan, Yujuan, et al.
Foilsithe / Cruthaithe: (2017)

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
de réir: Elizabeth A. Eckman, et al.
Foilsithe / Cruthaithe: (2006)

The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
de réir: Kimberly Boland, et al.
Foilsithe / Cruthaithe: (1996)

TDP-43 expression influences amyloid β plaque deposition and tau aggregation
de réir: Davis, Stephani A., et al.
Foilsithe / Cruthaithe: (2017)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
de réir: Stephani A. Davis, et al.
Foilsithe / Cruthaithe: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
de réir: Korshavn, Kyle J., et al.
Foilsithe / Cruthaithe: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
de réir: Kyle J. Korshavn, et al.
Foilsithe / Cruthaithe: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
de réir: Garai, Kanchan, et al.
Foilsithe / Cruthaithe: (2014)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
de réir: Kanchan Garai, et al.
Foilsithe / Cruthaithe: (2014)

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme
de réir: Shuyu Liu, et al.
Foilsithe / Cruthaithe: (2014)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
de réir: Du, Wen-Jie, et al.
Foilsithe / Cruthaithe: (2015)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
de réir: Wenjie Du, et al.
Foilsithe / Cruthaithe: (2015)

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
de réir: Mikhail Matveyenka, et al.
Foilsithe / Cruthaithe: (2025)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
de réir: Wang, Qiuming, et al.
Foilsithe / Cruthaithe: (2013)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
de réir: Qiuming Wang, et al.
Foilsithe / Cruthaithe: (2013)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
de réir: Hemming, Matthew L., et al.
Foilsithe / Cruthaithe: (2005)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
de réir: Larmuth, Kate M., et al.
Foilsithe / Cruthaithe: (2016)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
de réir: Matthew L. Hemming, et al.
Foilsithe / Cruthaithe: (2005)

A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition
de réir: Hou, Li‐Na, et al.
Foilsithe / Cruthaithe: (2013)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
de réir: Jin, Sha, et al.
Foilsithe / Cruthaithe: (2016)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
de réir: Sha Jin, et al.
Foilsithe / Cruthaithe: (2016)

β‐Amyloid aggregation and heterogeneous nucleation
de réir: Srivastava, Atul K., et al.
Foilsithe / Cruthaithe: (2019)

β‐Amyloid aggregation and heterogeneous nucleation
de réir: Atul Srivastava, et al.
Foilsithe / Cruthaithe: (2019)

Aggregation and structure of amyloid β-protein
de réir: Kenjiro Ono, et al.
Foilsithe / Cruthaithe: (2021)

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
de réir: Takami Tomiyama, et al.
Foilsithe / Cruthaithe: (1996)

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity
de réir: Wang, Peng, et al.
Foilsithe / Cruthaithe: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
de réir: Kehoe, Patrick Gavin, et al.
Foilsithe / Cruthaithe: (2016)